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Background: Retinal ischemia results in a progressive degeneration of neurons and a pathological activation of
glial cells, resulting in vision loss. In the brain, progressive damage after ischemic insult has been correlated to
neuroinflammatory processes involving microglia. Galectin-3 has been shown to mediate microglial responses to ischemic
injury in the brain. Therefore, we wanted to explore the contribution of Galectin-3 (Gal-3) to hypoperfusion-induced retinal
degeneration in mice.
Methods: Gal-3 knockout (Gal-3 KO) and wildtype (WT) C57BL/6 mice were subjected to chronic cerebral hypoperfusion
by bilateral narrowing of the common carotid arteries using metal coils resulting in a 30% reduction of blood flow. Sham
operated mice served as controls. After 17 weeks, the mice were sacrificed and the eyes were analyzed for
retinal architecture, neuronal cell survival, and glial reactivity using morphological staining and immunohistochemistry.
Results: Hypoperfusion caused a strong increase in Gal-3 expression and microglial activation in WT mice, coupled with
severe degenerative damage to all retinal neuronal subtypes, remodeling of the retinal lamination and Müller cell gliosis.
In contrast, hypoperfused Gal-3 KO mice displayed a retained laminar architecture, a significant preservation of
photoreceptors and ganglion cell neurons, and an attenuation of microglial and Müller cell activation.
Conclusion: Moderate cerebral blood flow reduction in the mouse results in severe retinal degenerative damage.
In mice lacking Gal-3 expression, pathological changes are significantly attenuated. Gal-3 is thereby a potential
target for treatment and prevention of hypoperfusion-induced retinal degeneration and a strong candidate for
further research as a factor behind retinal degenerative disease.
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Ischemia, a pathological condition caused by inadequate
blood flow, is a highly deleterious condition when affect-
ing the central nervous system. In patients, chronic cere-
bral hypoperfusion is a common cause of cognitive
impairment and a key characteristic of pathologies such
as vascular dementia [1,2]. This type of insult is charac-
terized by progressive neuronal degeneration, gliosis,
and diffuse demyelination; however, the mechanism be-
hind this progression remains unclear.* Correspondence: linnea.taylor@med.lu.se
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article, unless otherwise stated.In addition to neurological impairment in the brain,
chronic cerebral hypoperfusion induced by stenosis or oc-
clusion of the common carotid arteries has been found to
lead to retinal and optic nerve degeneration in several ex-
perimental animal models [2-6]. Similar to the progressive
pathological process seen in the brain, retinal degeneration
following chronic occlusion of the common carotid arteries
occurs in several stages. Microglial activation has been ob-
served within the first 24 h, apoptosis of retinal ganglion
cells after 1 week, followed by death of inner retinal neu-
rons after 2 months and photoreceptors after 4 months [3].
Similar results have been obtained after transient occlusion
of the middle cerebral artery, which has been found toCentral. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
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ganglion cell death [7]. The microglial activation is a prom-
inent feature of infarct lesions resulting from ischemic in-
sults in the brain [8]. Uncontrolled activation and
inflammation is thought to be one of the major contribut-
ing factors to the progressive neurodegeneration and result-
ing neurological impairment seen in ischemia [9]. Although
microglial reactivity has been shown to have some benefi-
cial effects, prolonged and dysregulated activation can
exacerbate the pro-inflammatory process and thereby
increase neurotoxicity [10]. Retinal neuroinflammation
is a relatively new area of research, and the correlation
between inflammatory factors and detrimental processes
such as gliosis during injury and disease has so far been
largely unexplored.
One of the mediators of microglial activation and inflam-
mation during ischemic brain injury is the carbohydrate-
binding protein Galectin-3 (Gal-3) [11]. Previous studies
have shown that Gal-3 is required for microglial activation,
and that it can contribute to the early inflammatory
process, as well as enhancing post-ischemic tissue remodel-
ing [11,12]. Recently, we demonstrated that Galectin-3 is a
key player in alpha-synuclein-induced inflammation, rele-
vant to Parkinson’s disease [13]. In the retina, increased
Gal-3 expression has been implicated in the pathological
process in diabetic retinopathy, light-induced degeneration,
and retinal detachment [14,15]. However, its contribution
to ischemic injury has so far not been elucidated.
For this study, our hypothesis was that Gal-3 is a medi-
ator of neuroinflammation and neuronal cell death in
hypoperfusion-induced retinal degeneration. Using a pre-
viously established microcoil carotid stenosis model in
Gal-3 null mice with a pure C57BL/6 background as well




Gal-3 null mice [16] with a pure C57BL/6 background
were obtained originally from Dr. K. Sävman from the
Gothenburg University and bred at the Lund University
(Sweden). Mice were housed under a 12 h light/12 h
dark cycle with access to food and water ad libitum. All
procedures were carried in accordance with the inter-
national guidelines and were approved by the Malmö-
Lund Ethical Committee for Animal Research in Sweden
(M425-12).
The operation procedure has been well described previ-
ously [2] and will be summarized here. Age-matched male
mice (5 to 8 months wildtype mice, C57BL/6 (wildtype
(WT), n = 17) and Gal-3 knockout mice (n = 18) with
C57BL/6-background were used. Both WT and KO
mice were generated from littermate breeding couples
to minimize genetic variation between the WT and KOmice. WT mice (n = 12) and Gal3-KO mice (n = 12)
were subjected to hypoperfusion of the brain (WT
hypo). Sham operations were also performed, WT (n = 5)
and Gal3-KO (n = 6). For the hypoperfusion and sham op-
erations, mice were anesthetized with 5% isofluorane and
anesthesia was maintained at 2% isofluorane in oxygen.
The common carotid arteries were exposed with a small
neck incision. For hypoperfusion, metal coils (wire diameter
of 0.08 mm; inner diameter (ID): 0.18 mm; pitch : 0.50 mm;
total length: 2.5 mm; surface: Au-coated (Invitrotech Co.,
LTD, Shimogasa-cho Kusatsu, Shiga, Japan) were
encircled onto the common carotid arteries, reducing
blood flow to about 70% [2]. Anesthesia was discontinued
after 15 min, and the wound was sealed and locally anes-
thetized with Marcain (Bupivacaine, Apoteket, Umeå,
Sweden) 1.25 mg/kg. The sham operated mice were ex-
posed to the same procedure but had no coils inserted. 17
weeks post surgery, the animals were sacrificed using 5%
isofluorane and the eyes enucleated. Immediately after enu-
cleation, the eyes were fixed in 4% paraformaldehyde in 0.1
M phosphate buffer, pH 7.2 for 4 h at 4°C.Histology
Histological examinations were performed as previously de-
scribed [17], and only briefly recapped here. After fixation,
the eyes were macroscopically inspected, and infiltrated
with 0.1 M Sörensens medium with increasing concentra-
tions of sucrose, up to 25%, for cryoprotection. They were
then embedded in egg albumin/gelatine medium for cryo-
sectioning at −20°C with a section thickness of 12 μm. For
light microscopy, every 10th slide was stained with
hematoxylin and eosin (HTX). For immunohistochemical
labeling, adjoining slides were chosen. The specimens were
rinsed 3 times with PBS containing 0.1% Triton- X, and
then incubated with PBS containing 1% bovine serum albu-
min (BSA) for 20 minutes at room temperature. After this,
the specimens were incubated overnight at 4°C with the re-
spective primary antibody (Table 1). In the double labeling
for glutamine synthetase (GS)/bFGF, NeuN/Recoverin,
Gal-3/Iba-1, Gal-3/glial fibrillary acidic protein (GFAP) and
Gal-3/cellular retinaldehyde-binding protein (CRALBP)
both primary antibodies were added at this stage. The
specimens were then rinsed in PBS-Triton-X (0.1%)
and incubated for 45 min with a secondary fluorescein
isothiocyanate (FITC) or Texas Red-conjugated anti-
body (Table 1). In the double labeling for GS/bFGF,
NeuN/Recoverin, Gal-3/Iba-1, Gal-3/GFAP, and Gal-3/
CRALBP both secondary antibodies were added at this
stage. The specimens were then mounted in Vectashield
mounting medium with 4′,6-diamidino-2-phenylindole
(DAPI; Vector laboratories Inc., CA, USA). Negative
control experiments were performed as above, re-
placing the primary antibody with PBS containing 1%
Table 1 Table of primary and secondary antibodies used for immunohistochemical analysis
Antibody name Target cell Species Dilution Source
Antigen
Neuronal nuclei (NeuN) Anti-neuronal nuclei Ganglion cells Mouse
monoclonal
1:100 Millipore, USA
Glutamine synthetase (GS) Rabbit anti-GS Müller cells Rabbit polyclonal 1:200 Abcam, Cambridge, UK
Recoverin Anti-recoverin Rod and cone
photoreceptors
Rabbit polyclonal 1:10,000 Chemicon International, CA, USA
Rhodopsin Rho4D2 Rod photoreceptor Mouse
monoclonal
1:100 Kind gift of Prof. RS Molday,
Vancouver, Canada
Iba-1 Rabbit anti-Iba-1 Microglia Rabbit polyclonal 1:500 Wako Pure Chemical Industries Ltd.,
Osaka, Japan/Nordic biolabs
Galectin-3 Galectin-3 antibody Mainly microglia Rat 1:300 Hakon Leffler
Calbindin Anti-calbindin D-28K Horizontal cells Mouse
monoclonal
1:200 Sigma Aldrich, St Louis, MO, USA








1:200 Chemicon International, CA, USA
PKCpan Phospho-PKC (pan) Rod bipolar cells Rabbit polyclonal 1:200 Cell Signaling, Beverly, MA, USA
Cellular retinaldehyde-binding
protein (CRALBP)
Anti-CRALBP [B2] Müller cells Mouse
monoclonal






Anti-mouse Goat 1:200 Sigma Aldrich, St Louis, MO, USA
Texas red Texas red dye-conjugated
AffiniPure
Anti-rabbit Donkey 1:200 Jackson ImmunoResearch, PA, USA
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tive control.
Microscopy and image analysis
The histological sections and immunohistochemically la-
beled specimens were examined using an epifluores-
cence microscope (Axiophot; Zeiss, Oberkochen, West
Germany) equipped with an Olympus digital camera sys-
tem (Olympus, Tokyo, Japan) and a digital acquisition
system (DP 70; Olympus, Tokyo, Japan). Double-labeled
specimens were viewed using an optical and epifluores-
cence microscope (Axio Imager M2, Carl Zeiss Micros-
copy GmbH, Jena, Germany) equipped with a digital
camera system (AxioCam MRm, Carl Zeiss) and a digital
acquisition system (ZEN 2012 blue edition, Carl Zeiss).
Confocal images of Iba1/Gal-3 and Gal-3/CRALBP la-
belings were obtained using a Nikon A1 Confocal on a
Ti-E microscope (Nikon, Chiyoda-ku, Tokyo, Japan) and
processed using NIS-Elements (Nikon, Chiyoda-ku,
Tokyo, Japan). Photographs for panels were taken cen-
trally. Images were viewed and processed using Photo-
shop (Adobe Systems, Mountain View, CA, USA).
Statistical analysis
To statistically quantify survival of individual cell types,
sections derived from HTX as well as immunohisto-
chemistry were used. Ganglion cell and photoreceptorsurvival, as well as bipolar cell length, was analyzed
using cell counts in NeuN labelings, labeled cell rows
in recoverin labelings, and length measurements in
PKCpan labelings. These analyses were performed as
previously described [18-20]. In brief, one central
photograph and one at the mid-periphery (two central
and two from mid-periphery with PKCpan), taken using
a fixed exposure time, were analyzed per retina from a
central section (including the optic nerve). Cells in the
ganglion cell layer (GCL) labeled with NeuN (ganglion
cells) and vertical cells rows labeled with recoverin
(photoreceptors) were counted, and the length of
PKCpan-labeled bipolar cells was measured at 40×
magnification. For photoreceptor rows, two rows were
counted per image. For PKCpan width, one bipolar cell
length was counted per image. All retinal sections were
processed in the same batch for each immunohisto-
chemical staining. Fluorescence intensity was used as a
tool to quantify GFAP, GS, Iba1, and Galectin-3 labeling
and was analyzed using ImageJ (Rasband, W.S., ImageJ,
U. S. National Institutes of Health, Bethesda, Maryland,
USA, http://imagej.nih.gov/ij/, 1997 to 2014). For each
image, a rectangular area (fixed for each batch) was ana-
lyzed, placed within the area of interest, that is, from the
NFL to outer limiting membrane, ensuring the measure-
ments were not influenced by autofluorescence from inner
and outer segments. The background, obtained from
Figure 1 Hematoxylin and eosin staining of retinal sections. (A) WT
control animals reveal clearly defined nuclear and plexiform layers.
(B) WT hypo mouse retinas reveal thin and highly disorganized cell
and plexiform layers with numerous pyknotic cells (arrow).The ganglion
cell layer appear thin and is populated by small cell bodies. The smaller
picture shows a central section of a WT hypo specimen with
almost no survival. (C) KO control mice display clearly defined
nuclear and plexiform layers. (D) Hypoperfused Gal-3 knockout
mouse retinas (KO hypo) show a clearly laminated architecture
with well populated cell layers. Scale bar = 50 μm.
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escence measurement was noted as previously described
[21]. Data were analyzed using two-way ANOVA with a
Tukey post hoc test (GraphPad InStat; GraphPad Software,
San Diego, CA, USA). Raw data from intensity measure-
ments and cell counts were used to generate mean values




Macroscopic inspection revealed no retinal neovascu-
larization or retinal hemorrhages. Hematoxylin and
eosin staining of WT and Gal3-KO controls, as well as
Gal3-KO hypoperfused retinas, revealed clearly defined
nuclear and plexiform layers (Figure 1A,C,D). In con-
trast, hypoperfused wildtype mouse retinas (WT hypo)
revealed thin and highly disorganized nuclear layers
with numerous pyknotic cells, as well as a thinning of
the inner plexiform layer (IPL) and an almost complete
loss of the outer plexiform layer (OPL; Figure 1B). The
ganglion cell layer was populated by small cell bodies.
Immunohistochemistry
NeuN labeling revealed numerous large cell bodies of
ganglion morphology in the GCL in both WT and KO
controls, with no significant difference in the number
of cells (Figure 2A,C,E). In WT hypo specimens, only
isolated cell bodies were seen (Figure 2B). In contrast,
KO hypo counterparts revealed significantly more labeled
cell bodies present in the GCL (Figure 2D,E; P < 0.05). WT
hypo specimens also had significantly fewer ganglion cells
compared to corresponding controls (P < 0.001; Figure 2E).
In both WT and KO control retinas, recoverin and
rhodopsin labelings were present in photoreceptor
outer segments (OS) at the outer border of the retina,
as well as weaker labeling of inner segments (IS) and
photoreceptor cell bodies (Figure 3A,B,F,G). WT hypo
specimens displayed recoverin labeling similar to that
seen in corresponding controls, albeit with significantly
fewer labeled cell rows present (P < 0.001; Figures 3C
and 4). In these specimens, higher rhodopsin labeling
intensity was found in the IS/OS as well as displaced
rhodopsin expression in scattered photoreceptor cell
bodies (Figure 3D). Similarly, recoverin-labeled KO hypo
retinas were comparable to the corresponding controls
with no significant difference in the number of labeled
cell rows, although an increase in rhodopsin labeling of IS/
OS and cell bodies was observed (Figures 3G,H and 4).
PKCpan labeling of WT and KO controls showed
strong labeling of a multitude of well organized bipo-
lar cells and their processes in the inner nuclear layer
(INL) and IPL, respectively (Figure 5A,C). In contrast
to the control specimens, WT hypo specimensdisplayed shortened bipolar cells with disorganized
cell bodies and terminals and sprouting processes, a
behavior indicative of photoreceptor degeneration, in
Figure 2 Immunohistochemical labeling of ganglion cells. (A) WT control retinas reveal large cell bodies of ganglion morphology in the GCL.
(B) WT hypo mice show only isolated cell bodies in the GCL. (C) KO control animals show plentiful large cell bodies of ganglion morphology
in the GCL. (D) KO hypo retinas reveal large cell bodies in the GCL. Scale bar = 50 μm. (E) Statistical analysis of NeuN-labeled ganglion cells in
the GCL. No significant difference between WT and KO control animals. Significantly fewer ganglion cells in WT hypo animals compared to corresponding
controls and KO hypo retinas (P < 0.001; P < 0.05, respectively). Error bars SEM. *P < 0.05; **P < 0.01; ***P < 0.001.
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[22]. In KO hypo counterparts, bipolar cells retained
their organization and displayed no sprouting, as well
as displaying significantly preserved cell span compared to
WT hypo specimens (P > 0.001; Figure 5D,I). Calbindin
labeling of WT and KO control retinas revealedhorizontal cell bodies and their processes in the INL
and OPL, respectively (Figure 5E,G). In WT hypo
counterparts, only weak scattered labeling of unidenti-
fied structures was found (Figure 5F). In contrast, KO
hypo retinas revealed labeling similar to that seen in
control specimens (Figure 5H).
Figure 3 Immunohistochemical labeling of photoreceptor cells. (A) Recoverin-labeled WT control retinas reveal labeling of outer segment at the
outer border of the retina, as well as weaker labeling of inner segments and photoreceptor cell bodies. (B) Rhodopsin labeling of WT control animals
shows inner and outer segments as well as photoreceptor cell bodies in the ONL. (C) WT hypo retinas display recoverin labeling of disorganized inner
and outer segments as well as labeling of photoreceptor cell bodies. (D) WT hypo specimens display strong rhodopsin labeling of outer segments and
labeling of inner segments and photoreceptor cell bodies. The specimens show a disorganized appearance as well as displaced rhodopsin expression
to cell bodies in the outer nuclear layer (arrows). (E) KO control retinas reveal recoverin labeling of inner and outer segments as well as photoreceptor
cell bodies. (F) Rhodopsin labeling of KO control animals shows strong labeling of inner and outer segments and weaker labeling of photoreceptor cell
bodies. (G) Recoverin-labeled KO hypoperfused retinas display labeling of inner and outer segments as well as photoreceptor cell bodies. (H) KO hypo
mice reveal very strong labeling of the outer segments and weaker labeling of inner segments. Some displacement of rhodopsin expression to cell
bodies in the ONL is observed. Scale bar = 50 μm.
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revealed scattered astrocytes and Müller cell endfeet
present at outer border of the specimens, as well as iso-
lated Müller cell processes in the INL and ONL, with
no significant difference in labeling intensity (Figures 6A,C
and 7A). Strong labeling of vertical, hypertrophic Müller
cell fibers spanning the entire width of the retina was
present in WT hypo specimens (Figure 6B). In contrast, la-
beling of KO hypo retinas appeared similar to the corre-
sponding controls (Figure 6D). GFAP fluorescence intensity
was significantly higher in WT hypo animals compared to
their corresponding controls and KO hypo specimens
(P < 0.01 and P < 0.05, respectively, Figure 7A). GS label-
ing was found throughout the specimen in both WT
and KO control retinas, with no significant differencein fluorescence intensity (Figures 6E,G and 7B). Hypo-
perfused animals in both groups displayed a similar la-
beling pattern (Figure 6F,H), although the fluorescence
intensity was found to be significantly lower in the
WT retinas compared to the corresponding controls
(P < 0.05; Figure 7B).
Iba1 labeling of WT and KO control retinas was
used to reveal parenchymal cells as well as possible
blood-born macrophages and showed cells of a rami-
fied microglial morphology present mainly in the
plexiform layers (Figure 8A,C), with no significant dif-
ference in labeling intensity between the two groups
(Figure 9A). Hypoperfused WT specimens revealed
numerous ramified and amoeboid cells resembling
microglia present throughout the retina, with isolated
Figure 4 Statistical analysis of recoverin-labeled vertical photoreceptor cell rows. No significant difference is seen between WT control, KO control,
and KO hypo retinas. Significantly fewer ONL cell rows are found in WT hypo specimens compared to KO hypo retinas as well as corresponding
controls (P < 0.001). Error bars SEM. *P < 0.05; **P < 0.01; ***P < 0.001.
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The fluorescence intensity was significantly higher com-
pared to that of corresponding control and KO hypo ret-
inas (P < 0.001; Figure 9A). KO hypo specimens appeared
similar to control retinas with no significant difference in
labeling intensity compared to the controls (Figures 8E
and 9A). No Gal3 labeling was found in WT and KO
control animals, with no difference in labeling intensity
(Figures 8E,G and 9B). In contrast, the WT hypo ret-
inas displayed strong, irregular Gal-3 labeling of struc-
tures scattered throughout all three nuclear layers
(Figure 8F), with a significantly higher labeling intensity
compared to WT control specimens (P < 0.001; Figure 9B).
Labeling of KO hypo animals appeared similar to, and
did not significantly differ in intensity from, that found
in the corresponding controls (Figures 8H and 9B). A
double labeling of Gal-3 and Iba1 revealed colocalization of
small, round Gal-3-positive structures in the cell bodies of
microglia in the WT hypo specimens (Figure 10A,B,C,D,E
and Additional file 1). In addition, Iba1-labeled micro-
glia were most often seen adjacent to Gal-3 positive
structures resembling debris (Figure 10A,B,C). No colo-
calization of Iba1 and Gal-3 was found in any of the
other groups (not shown). Double labelings of Gal-3/
CRALBP and Gal-3/GFAP revealed no colocalizationof these two proteins in WT hypo retinas (Figure 11A,B,C),
not in any of the other groups (not shown).
Discussion
Summary
In this study, we have explored the contribution of
Galectin-3 to the retinal degeneration observed in a
chronic carotid stenosis model, which in the brain has
been used as a model of vascular dementia [2-6]. Pre-
vious studies have described progressive retinal degen-
eration as a result of hypoperfusion through the
common carotid arteries in several animal models,
even after baseline blood flow has been restored
[4,23-25]. This pathological process is associated with
an increased GFAP expression in Müller cells, one of
the hallmarks of reactive gliosis following neuronal in-
jury, as well as microglial activation and metabolic
stress; however, the mechanism of progression has yet
to be fully elucidated [3,26,27]. In the brain, progres-
sive neurological damage following ischemic insult is
thought to be largely due to neuroinflammatory processes,
in which dysregulated cytokine, neurotrophic factor, and
protease production is thought to play a major part [28-30].
Gal-3, a cytokine with β-galactoside-binding properties,
has been implicated in glial neuroinflammatory activity
Figure 5 Immunohistochemical labeling of bipolar cells (PKCpan), horizontal cells (Calbindin). A-D PKCpan. E-H Calbindin. (A) WT control animals
show numerous well organized bipolar cells and their processes in the INL and IPL, with strong labeling intensity present in the cell bodies in the
INL. (B)WT hypo retinas display short bipolar cells with disorganized cell bodies and terminals and sprouting processes in the ONL (arrows). (C) KO control
retinas show a multitude of well organized bipolar cells and their processes in the INL and IPL, respectively. Strong labeling is present in the
terminals in the IPL and the cell bodies in the INL. (D) KO hypo specimens display numerous bipolar cells and processes in the INL and IPL,
with retained organization and no sprouting. (E) WT control retinas reveal horizontal cell bodies and their processes in the INL and OPL, respectively.
(F) WT hypo animals, no labeled cells are seen; however, scattered labeling of unidentified structures is present. (G) KO control animals display
horizontal cell bodies and their processes in the INL and OPL. (H) KO hypo specimens reveal horizontal cell bodies and their processes in the INL and OPL.
Scale bars = 50 μm. (I) Statistical analysis of PKCpan width (bipolar cell length) in the INL and OPL. Significantly shorter bipolar cells in WT hypo animals
compared to corresponding controls and KO hypo retinas (P < 0.001 for both comparisons). Error bars SEM. *P < 0.05; **P < 0.01; ***P < 0.001.
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Figure 6 Immunohistochemical labeling of activated Müller cells and astrocytes (GFAP) and Müller cell (GS). (A-D) GFAP. (E-H) GS. (A) WT control
retinas show scattered astrocytes and Müller cell endfeet present at outer border of the specimens, as well as isolated Müller cell processes in the
IPL. Isolated retinal vessels are labeled in the INL. (B) WT hypo specimens display strong labeling of hypertrophic Müller cell fibers spanning the
entire vertical width of the retina. (C) KO control specimens display labeling of scattered astrocytes and Müller endfeet at the outer border of the
specimens and isolated blood vessels in the inner layers. (D) KO hypo mice show a discontinuous band of labeled astrocytes and Müller endfeet
at the inner border, as scattered retinal vessels in the inner layers. (E) WT control animals reveal strong GS labeling throughout the specimens. (F)
In WT hypo mice, GS labeling is present throughout the whole retina. (G) KO control animals reveal strong GS labeling throughout the retina. (H)
Hypoperfused KO mice display GS labeling throughout the retina. Scale bars = 50 μm.
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cantly upregulated in microglia in the brain following
focal ischemia, where it contributes to post-ischemic
tissue remodeling [12,31]. Similarly, several retinal de-
generative diseases associated with GFAP elevation and
gliosis in Müller cells, including diabetic retinopathy
and light-induced retinal degeneration, have also been
linked to an increased expression of Gal-3 [14,15,32].
In this study, we have for the first time shown that the
absence of Gal-3 significantly attenuates glial reactivity
during hypoperfusion-induced retinal degeneration and
significantly preserves photoreceptors and ganglion
cells, as well as the retinal laminar morphology.Retinal effects of chronic cerebral hypoperfusion
One of the most commonly used models to investigate
the effects of chronic ischemia is to permanently oc-
clude the common carotid arteries in rats, which dras-
tically reduces cerebral flow [6,33]. However, in this
model, it is unclear to which extent the retina becomes
hypoperfused [3,6,25,34]. For this study, we chose mice
from a pure C57BL/6 background, a strain, which due
to its poorly developed circle of Willis, is highly suscep-
tible to cerebral ischemia through carotid artery occlu-
sion [34-37]. When comparing various species and
mouse strains for suitability as models for ischemia,
Yang et al. found C57BL/6 mice to show a high
Figure 7 Statistical analysis of GFAP and GS labeling fluorescence intensity. (A) Fluorescence intensity of GFAP labeling measured by ImageJ. No
significant difference is observed between WT controls, KO control, and KO hypo specimens. Hypoperfused wildtype animals show a significantly
higher fluorescence intensity compared to KO hypo specimens as well as the corresponding controls (P < 0.01; P < 0.05), respectively. Error bars
SEM. (B) Fluorescence intensity of GS labeling measured by ImageJ. No significant difference in fluorescence intensity is found between WT control, KO
control, and KO hypo specimens. Significantly lower fluorescence intensity is seen in hypoperfused wildtype retinas compared to the
corresponding controls (P < 0.05). Error bars SEM. *P < 0.05; **P < 0.01; ***P < 0.001.
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resultant ischemic lesions [34].
Investigations of the retinal cellular effects of permanent
carotid artery occlusion report reactive gliosis and progres-
sive neuronal cell death, in which the ganglion cells are
among the first affected [3,6,23,37]. Interestingly, transient
retinal ischemia, induced by elevated intraocular pressure,
results in similar progressive degeneration beginning withinner retinal neurons, where one study found 71% fewer
optic axons 5 months after insult [38,39]. Primary patho-
logical events causing neuronal damage during ischemic in-
jury to the CNS, in addition to the loss of circulation,
include excitotoxic glutamate release from neurons and glia
[24]. In the eye, increased levels of glutamate have been
found in the vitreous during retinal ischemia [40]. Excess
glutamate is normally removed by Müller cells through
Figure 8 Immunohistochemical labeling of microglia and Gal3 expression. (A-D) Iba1. (E-H) Gal3. (A) Iba1-labeled WT control mice show
scattered, ramified microglia present in the plexiform layers. (B) Hypoperfused WT animals display numerous microglia of both ramified
and amobeoid morphology present throughout the retina, with isolated amobeoid cells in the outermost layers. (C) KO control retinas display ramified
microglial cells in the plexiform layers. (D) A similar labeling pattern and cell morphology is seen in KO hypo mice. (E) WT control animals
show no Gal-3 labeling. (F) Hypoperfused WT retinas show striated labeling spanning all nuclear layers with strongly labeled scattered structures in the
inner layers. (G) KO control animals reveal no labeling of Gal-3. (H) Hypoperfused KO mice display no labeling of Gal-3. Scale bars = 50 μm.
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city [41]. However, in the post-ischemic retina, the homeo-
static functions of Müller cells, such as glutamate uptake,
ion buffering, and water balance are reduced, which con-
tributes to neuronal damage [24,41]. The sustained glial ac-
tivation after ischemia and loss of normal retinal metabolic
activity is thought to be responsible for the secondary, pro-
gressive neuronal cell death [24,25], although the precise
mechanism behind this phenomenon has not been fully
elucidated.
In our study, the coils reduced the blood flow through
the common carotid arteries to approximately 70% of nor-
mal values [2]. After 17 weeks, WT mice displayed an up-
regulation of Gal-3 expression, a significant loss of ganglion
cells (P < 0.001) and photoreceptors (P < 0.001) and disrup-
tion of horizontal cells and bipolar cells (P < 0.001).Evidence of remodeling was also seen, where the overall
morphology revealed disorganization of the retinal lamin-
ation, and PKCpan-labeled bipolar cells displayed sprouting
into the ONL, a behavior associated with photoreceptor de-
generation [42]. Müller cell GS expression was significantly
downregulated, an event associated with gliosis, suggesting
impaired glutamate uptake. Indeed, GFAP expression, con-
sidered the hallmark of gliosis, was significantly increased,
as was Iba1, indicating activation of both Müller cells and
microglia [41,43]. Since Iba1 also labels blood-born macro-
phages and we have previously shown that bilateral carotid
artery occlusion in CD57bl/6 mice causes macrophage infil-
tration in the brain, we cannot exclude a macrophage con-
tribution also in the ischemic retina [44].
In contrast to the WT hypoperfused mice, Gal-3 KO
counterparts displayed no significant neuronal loss or
Figure 9 Statistical analysis of Iba-1 and Gal3 labeling fluorescence intensity. (A) Fluorescence intensity of Iba-1 labeling measured by ImageJ. No
significant difference between WT control, KO control, and KO hypo retinas. WT hypo animals show significantly higher fluorescence intensity
compared to all other groups (P < 0.001; P < 0.01; P < 0.01, respectively). Error bars SEM. (B) Fluorescence intensity of Gal-3 labeling measured by
ImageJ. No significant difference between WT control, KO control, and KO hypo specimens. Hypoperfused wildtype animals reveal a significantly
higher fluorescence intensity compared to all other groups (P < 0.001 for all comparisons). Error bars SEM. *P < 0.05; **P < 0.01; ***P < 0.001.
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We can therefore report that the reduction of cerebral
blood flow by 30% does not on its own appear to cause
any significant retinal injury in the absence of Gal-3.
The mechanism behind the activation and thesubsequent progression of Müller cell and microglial
gliosis after ischemic insult may involve a combination
of factors and crosstalk between these two cell types and
recruited macrophages, where our results suggest Gal-3
is a possible mediator.
Figure 10 Immunohistochemical labeling of Gal-3 (red), Iba-1 (green), and DAPI (blue), epifluorescent imaging and confocal imaging. (A) Double-labeled
WT hypo retinas with Gal-3/Iba-1 show colocalized expression of Gal3 in small, round structures in Iba1-labeled microglial cell bodies (arrow). (B) Confocal
linescan z-stack slice revealing two extra-nuclear Gal-3 inclusions in a microglial cell, adjacent to a large, non-uniform Gal-3 labeled structure (arrows). (C) A
three-dimensional rendered image of a microglial cell with two Gal-3 inclusions, adjacent to a Gal-3 positive structure. (D) Colocalized labeling
of Gal-3 inclusions (arrows) in an Iba1-positive microglial cell. (E) Iba1-positive cell with Gal3-labeled structure (arrow). Scale bars = 25 μm.
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Gal-3 has been found to act as a pro-inflammatory medi-
ator and has been implicated in numerous inflammatory
diseases. Gal-3 upregulation (up to 96-fold) has been re-
ported during several retinal pathologies and is thought to
be required for microglial activation following ischemia in
the brain [8,11,14,15,45,46]. The microglial response to in-
jury is extremely rapid, where cells become activated within
minutes, and is thought to precede macroglial responses
[23,26,27,47]. It has been suggested that in the injured ret-
ina, Müller cells release Gal-3 via unconventional secretion,
where it can then function as a microglial phagocytic ligand
[14,48,49]. Our group has recently shown that Gal-3 se-
creted by brain microglia can bind the TLR4 receptor and
in an autocrine fashion increase detrimental inflammation
[50]. Extracellular Gal-3 can act as a bridging molecule by
simultaneously binding to Mer receptor tyrosine kinase
(MerTK) and phagocytic prey, thereby stimulating phago-
cytosis [48,51,52]. Intracellular effects of Gal-3 includeenhancing microglial phagocytic activity through the activa-
tion of phosphatidylinositol-3-kinase (PI3K) via K-Ras
[48,53]. Gal-3 can be found in different subcellular com-
partments in a range of cell types, and together with its nu-
merous post-translational modifications has been found to
have a wide range of functions [50]. In this study, Iba1-
labeled cells appear to be the most likely source of Gal-3;
however, previous studies have shown Müller cells and as-
trocytes to be the main point of supply during retinal dis-
ease [14,54]. Double labelings of Gal-3 with Müller cell and
astrocytic markers GFAP (activated Müller cells and astro-
cytes) and CRALBP revealed no colocalization. In a clinical
setting, Gal-3 has been found in cerebrospinal fluid (CSF)
of infants with hypoxic-ischemic brain injury after birth as-
phyxiation, where it was found to contribute to detrimental
neuroinflammation [55]. This study evaluated the possible
systemic production and deposition in CSF of Gal-3, as well
as possible leakage of Gal-3 into the CSF through blood-
brain barrier (BBB) dysfunction. No difference was
Figure 11 Immunohistochemical labeling of Gal-3, with Müller cell markers GFAP and CRALBP, and DAPI; epifluorescent imaging and confocal
imaging of WT hypoperfused retinas. (A) A confocal linescan z-stack image of a double labeling of Gal-3/CRALBP show Gal-3 labeling of large
structures vertically spanning the inner layers (arrow), as well as scattered structures. No colocalized labeling of CRALBP and Gal-3 was found. (B) Confocal
image of Gal-3/CRALBP double labeling displays no colocalization. Large, vertical Gal-3 positive structures are present (arrow). C) Gal-3/GFAP double labeling
reveals no colocalization. Scale bars = 50 μm.
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fants and controls suggesting that there were no major con-
tribution resulting from BBB damage. To assess systemic
contribution of Gal-3 to the CSF, infants with septic inflam-
mation were screened, with no difference to controls, indi-
cating a local production of Gal-3 in the injured CNS [55].
Over time, the expression of Gal-3 remained elevated
within the clinically important group with moderate en-
cephalopathy, in similarity to our findings after 17 weeks.
The mechanism of action in which Gal-3 contributes to the
maintenance and progression of neuroinflammatory pro-
cesses in this setting may therefore involve the secretion of
Gal-3 from activated cells, resulting in induction of pro-
inflammatory cytokines such as interleukin (IL)-1β, tumor
necrosis factor (TNF) α, and IL-6, enhancing glial reactivity
through a positive feedback cycle and thereby contributing
to neuronal cell death [14,41,48,56-61].
In our study, Gal-3 expression was mainly found in large
structures resembling debris, as well as in inclusions in ad-
jacent Iba1-labeled cells of microglial morphology. The
appearance of cellular inclusions has previously beendescribed in macrophages in the brain, where Gal-3 has
been found to be a signal for phagocytosis of apoptotic
cells [48]. Similarly, the phagocytic activity of retinal acti-
vated microglia and astrocytes has been correlated to in-
creased Gal-3 expression and ganglion cell death after
glaucomatous injury [54]. In this setting, Gal-3 possibly
mediates dysregulated phagocytosis and glial activation,
which we have shown can be attenuated through Gal-3
KO. Gal-3 is therefore a promising target for pharmaceut-
ical intervention to minimize debilitating neuroinflamma-
tory degeneration in the retina after ischemic injury.
Conclusion
We have shown that a long-term moderate reduction of
cerebral blood flow through the common carotid arteries
results in degeneration of several retinal neuronal sub-
types, as well glial reactivity, in the mouse. In the ab-
sence of Gal-3, these reactions are attenuated, resulting
in a preservation of retinal neurons and the laminar
architecture. This suggests that Gal-3 may be a link be-
tween neuroinflammation and retinal gliosis. Our results
Manouchehrian et al. Journal of Neuroinflammation  (2015) 12:92 Page 15 of 16suggest that the neuroinflammatory processes propa-
gated by glial cells results in a neurotoxic environment
after ischemic injury, leading to progressive retinal dam-
age. The findings indicate that Gal-3 is a potential target
for the prevention of post-ischemic retinal pathology
and make Gal-3 an interesting candidate for further
study in retinal degenerative disease.
Additional file
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cell in a wild type hypoperfused retina. Three-dimensional image of an
activated microglial cell with Galectin-3 labeled inclusions in a wild type
hypoperfused retina. Confocal linescan-generated three-dimensional
image of an Iba1-labeled microglia (green) containing Galectin-3-positive
inclusions (red). Cell bodies labeled with DAPI (blue).
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